Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody

Transplantation

Volumn 64, Issue 12, 1997, Pages 1838-1843

  Sun, Hong ^a   Subbotin, Vladimir ^a   Chen, Christopher ^a   Aitouche, Abdelouahab ^a   Valdivia, Luis A ^a   Sayegh, Mohammed H ^b   Linsley, Peter S ^c   Fung, John J ^a   Starzl, Thomas E ^a   Rao, Abdul S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN GP 39; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY CD 40L; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA GRAFT; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, DIFFERENTIATION; AORTA; CD40 LIGAND; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; IMMUNOCONJUGATES; IMMUNOSUPPRESSION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

EID: 0031450625     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00035     Document Type: Conference Paper

References (12)

1. Stüber E, Strober W, Neurath W. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996; 183: 693.
2. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
3. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
4. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci USA 1996; 93: 12439.
5. Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH. CD28-B7 cell costimulatory blockade by CTLA4-Ig in the rat renal allograft model. Transplantation 1996; 62: 1942.
6. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the LEW to F344 rat model. J Clin Invest 1996; 97: 833.
7. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80.
8. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 1996; 61: 4.
9. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
10. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
11. Sun H, Valdivia LA, Subbotin V, et al. An improved surgical technique for the establishment of a murine model of aortic transplantation. Microsurgery 1996; 17.
12. Subbotin VM, Sun H, Aitouche A, et al. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation 1997; 64: 1.